Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

rather than changing diet, to control obesity. Novo Nordisk had hoped its “next generation” weight-loss drug could lead the field, after its shares had struggled to keep pace with Eli Lilly ...

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

The weight loss and diabetes drugs Wegovy and Ozempic have transformed the fortunes of Novo Nordisk, leading it to more than triple in value in the past five years. Barclays had previously modelled ...

No surprise that what was described as the first clinical comparative effectiveness study of tirzepatide (Mounjaro, Eli Lilly ... weight and make changes in diet and exercise habits.

Age, race, sex, environmental and lifestyle factors such as physical activity and diet are important determinants ... SERMs such as Evista (raloxifene, Eli Lilly) are used in pre-menopausal ...

Beauty queen Priscilla Meirelles shares in an Instagram post how she managed to lose her excess weight in just five months.